Brief: Galera To Present Supplemental Analysis Of Phase 3 Trial At European Congress On Head And Neck Oncology

Obsidian Therapeutics

10/03/2023 14:07

March 10 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES PRESENTATION OF SUPPLEMENTAL ANALYSIS OF
PHASE
3 ROMAN TRIAL AT EUROPEAN CONGRESS ON HEAD AND NECK ONCOLOGY

Source text for Eikon:  ID:nGNX7G1WMw 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))